Instituto Catalán de Oncología; Servicio de Farmacia
Barcelona, Barcelona 08907
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer
Studies at this site
Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer
— Completed